1. Volume 153, Issue 3, Pages 689-701.e1 (September 2017)
Tests for Serum Transglutaminase and Endomysial Antibodies Do Not Detect Most Patients With Celiac Disease and Persistent Villous Atrophy on Gluten-free Diets: a Meta-analysis 
Jocelyn A. Silvester, Satya Kurada, Andrea Szwajcer, Ciarán P. Kelly, Daniel A. Leffler, Donald R. Duerksen 
Gastroenterology 
Volume 153, Issue 3, Pages e1 (September 2017)
DOI: /j.gastro
Copyright © 2017 AGA Institute Terms and Conditions

2. Figure 1
Performance of tTG IgA for detection of persistent villous atrophy in patients with biopsy-confirmed celiac disease on a GFD. (A) Forest plot of sensitivity and specificity of tTG IgA for persistent villous atrophy on a GFD. (B) Summary ROC curve of tTG IgA for persistent villous atrophy. In addition to individual and summary points, the 95% confidence region (solid circle) denotes the precision of the pooled estimate of the available studies and the 95% prediction region (dashed circle) shows the area where the next study is likely to lie, which reflects variability among studies.
Gastroenterology  , e1DOI: ( /j.gastro )
Copyright © 2017 AGA Institute Terms and Conditions

3. Figure 2
Performance of EMA IgA for detection of persistent villous atrophy in patients with biopsy-confirmed celiac disease on a GFD. (A) Forest plot of sensitivity and specificity of EMA IgA for persistent villous atrophy on a GFD. (B) Summary ROC curve of EMA IgA for persistent villous atrophy. In addition to individual and summary points, the 95% confidence region (solid circle) denotes the precision of the pooled estimate of the available studies and the 95% prediction region (dashed circle) shows the area where the next study is likely to lie, which reflects variability among studies. 1Monkey, 2human.
Gastroenterology  , e1DOI: ( /j.gastro )
Copyright © 2017 AGA Institute Terms and Conditions